biosimilars for her2-targeted antibodies
Published 3 years ago • 10 plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
3:39
biosimilars for her2-targeted antibodies
-
7:40
practical considerations in integrating her2 biosimilars in clinical practice
-
2:10
trastuzumab biosimilars for her2-positive breast cancer
-
7:46
practical considerations in integrating her2 biosimilars in clinical practice
-
1:11
dr. hurvitz on importance of biosimilars in her2 breast cancer
-
0:34
her2-targeted therapies
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
4:34
her2 cancer treatment - resistance, immunologic implications, and biosimilars.mp4
-
4:37
combating 'financial toxicity' - her2 biosimilars and combinations with chemotherapy.mp4
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
1:50
findings of a biosimilar trastuzumab study in patients with her2-positive breast cancer
-
1:27
how will biosimilars affect treatment for breast cancer
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
0:59
sequencing her2-targeted therapies in breast cancer
-
0:59
dr. verma discusses biosimilars for trastuzumab
-
4:49
abp 980, a biosimilar antibody for trastuzumab
-
1:00
dr. dang on the significance of the myl-1401o biosimilar in her2-positive metastatic breast cancer
-
1:54
updates in treatments for her2-positive gea
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer